# Phase 5 Cycle3 Closure Memo - Phase 5 closes successfully

## Status

Phase 5 closed successfully. Phase 6 paper-trading dispatch AUTHORIZED.

## G4 verdict (locked in PR #189 / strategy-selection-v3.json)

Cycle3 ran 3 strategies. effective_trial_count = 3 per CF-29 + ADR-0023
LD-023-3 (independent per-cycle selection round). DSR penalty applied at
3 trials.

JSON sha256: C313CC4CB518B47485D1D32C7F03FB22F1CD90F38F8D573DB745308860441D76

| Strategy | Verdict | Sharpe | DSR | PSR_zero | Notes |
|---|---|---:|---:|---:|---|
| regime_shock_reversion_short_v2 | ADVANCE_TO_PAPER | 4.756 | 3.622 | 0.99999 | All 9 thresholds clear |
| vwap_overnight_reversal_short | REJECT | 2.328 | 0.635 | 0.932 | trade_count + hurdle + regime_trade fail |
| vwap_overnight_reversal_long | REJECT | -1.050 | -1.418 | 0.286 | 6/9 severe failures |

Summary: advance=1, reject=2, research_further=0, run_status=complete,
execution_fragility=false.

## Phase 5 closure decisions

### 1. Phase 6 paper-trading dispatch: AUTHORIZED

phase_6_dispatch_authorized=true is data-driven. regime_shock_reversion_
short_v2 is the first strategy in project history to clear the full
ADR-0016 Stage 1 inference layer. ADR-0018 walkthrough begins.

### 2. v2 advances to paper with explicit out-of-sample caveat

The in-sample Sharpe of 4.756 is exceptional. Per ADR-0016 LD-611-7,
PAPER-OBSERVATION is required before live capital. The framework
explicitly does NOT trust a single backtest result with live deployment;
the 45-60 trading day paper observation window validates persistence
out-of-sample. The 8-gate LIVE-PROMOTION review (LD-611-8) is the
further filter. LIVE-RAMP at 1->2->3 contracts (LD-611-5) gates capital
scaling.

The paper observation begins with QFA-614 (paper trading harness)
dispatch, after ADR-0018 + ADR-0020 walkthroughs, QFA-612 (Rithmic
adapter), QFA-613 (live data streaming).

### 3. Both vwap_overnight_reversal_* strategies retire from active

REJECT verdicts on the same corpus that v2 cleared. Both move to
REGISTERED_INACTIVE for Cycle4 if dispatched. The short-side strategy
showed alpha potential (Sharpe 2.33, PF 1.36, clean sensitivity) but
fires too rarely (39 trades < 300 minimum). Per CF-30/CF-41/CF-44:
no parameter tuning on the same strategy_id. Future cycle could test a
NEW strategy_id with different trigger geometry.

### 4. Cycle1+Cycle2 strategies remain REGISTERED_INACTIVE

8 strategies (4 from Cycle1 + 4 from Cycle2) stay registered but inactive.
Their verdicts and YAMLs remain byte-locked. They are not re-tested in
Cycle3 or any future cycle without a new strategy_id and new parameter
lock per CF-41/LD-023-2.

### 5. Cycle4 dispatch: DEFERRED

Phase 5 closes successfully with one ADVANCE_TO_PAPER. The Cycle4
decision (further hypothesis families, e.g., reversal at opening range
failure, microstructure-derived families, event-day filters) is
deferred until PAPER-OBSERVATION on v2 completes. If paper observation
validates v2's alpha, Cycle4 is non-urgent; if paper observation
reveals issues, Cycle4 dispatch becomes the primary research path.

## Open Phase 6 dispatch chain

The Cycle1-recovery governing plan §2.4 / Cycle3 governing plan §9
sequence is now active:

1. ADR-0018 walkthrough (R-Protocol integration shape; User decision)
2. ADR-0020 walkthrough (order latency SLA; User decision)
3. QFA-612 (Rithmic broker adapter; Codex implementation; ~3-6w)
4. QFA-613 (live data streaming client; Codex; ~2-4w; parallel with #3)
5. QFA-614 (paper trading harness; Codex; ~2-3w; after #3)
6. QFA-615 (live OMS + reconciliation; Codex; ~2-3w; after #3 + ADR-0020)
7. QFA-616 (kill-switch wiring; Codex; ~1-2w; after #6)
8. QFA-617 (operator console; Codex; ~1-2w; after #6)
9. QFA-618 (anomaly detection; Codex; ~1-2w; after #6 + #4)
10. QFA-619 (exchange-time discipline; Codex; ~1w; after #3)
11. ADR-0021 walkthrough (production deployment topology; User decision)
12. QFA-620 (production scaffolding; Codex; ~1w; after #11)
13. QFA-621-v2 (per-strategy live integration for regime_shock_reversion_
    short_v2 specifically; Codex; ~0.5-1w; after #5 + #6)
14. PAPER-OBSERVATION (45-60 trading day paper window per LD-611-7;
    Operational; ~9-12w; cannot be compressed)
15. LIVE-PROMOTION 8-gate review (LD-611-8; User decision)
16. LIVE-RAMP 1->2->3 contracts (LD-611-5; Operational; ~4-6w per step)

Coordinator decision required: dispatch ADR-0018 walkthrough first or
parallel with ADR-0020.

## Carry-forward additions from Cycle3 experience

- CF-52 (NEW): First-time ADVANCE_TO_PAPER strategies receive normal
  Phase 6 paper observation discipline; exceptional in-sample Sharpe
  does NOT justify compressed paper observation. The 45-60 trading day
  window per LD-611-7 is the data-grounded requirement; this number
  is not negotiable based on in-sample numbers alone. Per CF-45, only
  external methodological justification could revise this - not "the
  numbers look amazing."

## Trial accounting record

| Cycle | effective_trial_count | ADVANCE_TO_PAPER count | Phase 6 authorized? |
|---|---:|---:|---|
| Cycle1 | 4 | 0 | No |
| Cycle2 | 8 | 0 | No |
| Cycle3 | 3 | 1 | Yes (first time) |

Combined cycles: 4 + 8 + 3 = 15 strategies tested in total. 1 advanced.
Hit rate: 6.7% across all hypotheses tested. This is consistent with
the strict ADR-0016 methodology - the gate is meant to be hard.
